| |
|
| Product Responsibility |
| LOOKING AHEAD |
 |
The Generics market looks promising in the near future with a number of molecules going off patent in the next couple years. Through wide spread implementation of robust systems and processes like QbD we aim to synergise product quality, safety and compliance as we continue to pursue our goal to attain first-mover advantage. |
|
|
|
We expect Biosimilars to hold centre-stage in the coming years and our expertise in pharmacovigilance will be put to test. |
|
|
|
We are determined to restrict the proliferation of counterfeit medicines and will continue to invest in innovative packaging techniques. |
|
|
 |
| |
|
 |
|
| |
|
| |
|
|
|
|
|
